WuXi Biologics

Shanghai, CN · Wuxi, CN
CAR-T Cell Therapy AAV
Program data pending ClinicalTrials.gov matching · Last scored 2026-04-06
82.9
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (20) ✓ EMA GMP (3) ✓ MHRA GMP (1)

Quick Facts: WuXi Biologics

Signal Score
82.9/100 (as of 2026-04-06)
Quality Compliance
100.0/100 — No FDA inspection records found for this manufacturer
Headquarters
Shanghai, CN · Wuxi, CN
Modalities
CAR-T, Cell Therapy, AAV
Active Programs
No ClinicalTrials.gov matches confirmed — 5 partnership announcements in press
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

Signal Score & Pillar Breakdown

Quality Compliance 100.0
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Source: FDA Data Dashboard
No FDA inspection records found for this manufacturer · Quality score requires FDA inspection data
FDA InspectionsNo US records on file
EMA GMP Certificates3 on record
MHRA GMP Certificates1 on record
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer. 5 partnership announcements found in press monitoring.
Programs — no verified data
Sponsors— no verified data
ModalitiesCAR-T, Cell Therapy, AAV
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 68.0
Parent company: WuXi AppTec
Financial assessment: 68.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: WuXi AppTec
Financial assessment: 68.0/100
Capacity 68.0
2 manufacturing sites
Strong partnership activity (9 articles)
Sites: Shanghai, CN, Wuxi, CN
Source: SEC EDGAR, press monitoring, company profiles
2 manufacturing sites
Recent Press20 articles
2 manufacturing sites
Strong partnership activity (9 articles)

EMA GMP Compliance 3 certificates

2024-10
2024-10
2024-08
Compliant Non-Compliant
Certificate Site Country Inspection Date Status
35282/IMP13104/00001 Wuxi Biologics Ireland Limited Ireland 2024-10-11 COMPLIANT
35282/M13105/00001 Wuxi Biologics Ireland Limited Ireland 2024-10-11 COMPLIANT
DE_NW_03_GMP_2025_0079 WuXi Biologics Germany GmbH Germany 2024-08-23 COMPLIANT
Source: EMA EudraGMDP · Retrieved Apr 07, 2026

MHRA GMP Compliance 1 certificates

2025-08
Compliant Non-Compliant
Certificate Site City / Postcode Inspection Date Status
UK GMP 52290 Insp GMP 52290/19113162-0001[H] WUXI BIOLOGICS CO LIMITED CN-214092 2025-08-12 COMPLIANT
Source: MHRA GMDP Database · Retrieved Apr 07, 2026

Recent News 20 articles

general 2026-04-02
WuXi Biologics (Cayman) Inc. (2269.HK) stock price, news, quote and history - Yahoo Finance UK
WuXi Biologics (Cayman) Inc. (2269.HK) stock price, news, quote and history  Yahoo Finance UK
Source →
partnership 2026-03-30
WuXi Biologics Honored with CDMO Leadership Awards for Ninth Consecutive Year - PR Newswire
WuXi Biologics Honored with CDMO Leadership Awards for Ninth Consecutive Year  PR Newswire
Source →
regulatory 2026-03-30
Fiocruz deal with WuXi Biologics will strengthen Brazil's health industrial base - The Pharma Letter
Fiocruz deal with WuXi Biologics will strengthen Brazil's health industrial base  The Pharma Letter
Source →
partnership 2026-03-30
WuXi Biologics Honored with CDMO Leadership Awards for Ninth Consecutive Year - mykxlg.com
WuXi Biologics Honored with CDMO Leadership Awards for Ninth Consecutive Year  mykxlg.com
Source →
general 2026-03-25
WuXi Biologics Reports Record 2025 Annual Results, Operational Excellence Driven by Digital-Native Architecture - The Manila Times
WuXi Biologics Reports Record 2025 Annual Results, Operational Excellence Driven by Digital-Native Architecture  The Manila Times
Source →
general 2026-03-25
WuXi Biologics Reports Record 2025 Annual Results, Operational Excellence Driven by Digital-Native Architecture - Yahoo Finance Singapore
WuXi Biologics Reports Record 2025 Annual Results, Operational Excellence Driven by Digital-Native Architecture  Yahoo Finance Singapore
Source →
general 2026-03-25
WuXi Biologics reports record 2025 annual results - Vietnam Investment Review - VIR
WuXi Biologics reports record 2025 annual results  Vietnam Investment Review - VIR
Source →
general 2026-03-24
WuXi Biologics Reports Record 2025 Annual Results - Moomoo
WuXi Biologics Reports Record 2025 Annual Results  Moomoo
Source →
general 2026-03-24
WuXi Biologics Reports Record 2025 Annual Results - The Manila Times
WuXi Biologics Reports Record 2025 Annual Results  The Manila Times
Source →
general 2026-03-24
WuXi Biologics Reports Record 2025 Annual Results - The Manila Times
WuXi Biologics Reports Record 2025 Annual Results  The Manila Times
Source →
general 2026-03-24
WuXi Biologics Reports Record 2025 Annual Results - IT비즈뉴스
WuXi Biologics Reports Record 2025 Annual Results  IT비즈뉴스
Source →
general 2026-03-24
WuXi Biologics Reports Record 2025 Annual Results - Tirto.id
WuXi Biologics Reports Record 2025 Annual Results  Tirto.id
Source →
general 2026-03-24
WuXi Biologics Schedules Briefings on 2025 Annual Results for Global Investors - TipRanks
WuXi Biologics Schedules Briefings on 2025 Annual Results for Global Investors  TipRanks
Source →
general 2026-03-22
World Water Day: WuXi Biologics Advances Water Stewardship and Achieves Water Target - PR Newswire
World Water Day: WuXi Biologics Advances Water Stewardship and Achieves Water Target  PR Newswire
Source →
general 2026-03-22
World Water Day: WuXi Biologics Advances Water Stewardship and Achieves Water Target – Company Announcement - Financial Times
World Water Day: WuXi Biologics Advances Water Stewardship and Achieves Water Target – Company Announcement  Financial Times
Source →
general 2026-03-21
World Water Day: WuXi Biologics Advances Water Stewardship and Achieves Water Target - The Norfolk Daily News
World Water Day: WuXi Biologics Advances Water Stewardship and Achieves Water Target  norfolkdailynews.com
Source →
general 2026-03-20
Earendil Labs Taps WuXi Biologics to Accelerate Complex Antibody and ADC Pipeline - TipRanks
Earendil Labs Taps WuXi Biologics to Accelerate Complex Antibody and ADC Pipeline  TipRanks
Source →
partnership 2026-03-16
WuXi Biologics Awards Win And Earendil Deal Viewed Against Valuation - Yahoo Finance
WuXi Biologics Awards Win And Earendil Deal Viewed Against Valuation  Yahoo Finance
Source →
partnership 2026-03-14
WuXi Biologics Awards And Earendil Deal Shape Biologics Valuation Story - simplywall.st
WuXi Biologics Awards And Earendil Deal Shape Biologics Valuation Story  simplywall.st
Source →
partnership 2026-03-13
WuXi Biologics Wins Multiple Asia-Pacific Biopharma Excellence Awards for Leadership in Bioprocessing, Manufacturing Excellence, and Digital Innovation - PR Newswire
WuXi Biologics Wins Multiple Asia-Pacific Biopharma Excellence Awards for Leadership in Bioprocessing, Manufacturing Excellence, and Digital Innovation  PR Newswire
Source →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
CAR-T CDMOs → Cell Therapy CDMOs → AAV CDMOs →

Similar CDMOs

Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 92.2
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral
AGC Biologics
Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP
Signal Score: 80.2
CAR-T, Cell Therapy, AAV, Lentiviral
OmniaBio
Hamilton, ON
Signal Score: 79.5
AAV, Lentiviral, CAR-T, Cell Therapy
Made Scientific
Newark, NJ
Signal Score: 61.5
CAR-T, Cell Therapy, AAV
Cell and Gene Therapy Catapult
Stevenage, UK
Signal Score: 59.0
CAR-T, Cell Therapy, AAV